临床检测市场－全球产业规模、份额、趋势、机会及预测（按类型、最终用户、地区和竞争格局划分，2021-2031年）

全球临床检测市场预计将从 2025 年的 1,272.4 亿美元成长到 2031 年的 2,144.5 亿美元，复合年增长率为 9.09%。

这些专业的医学评估包括分析尿液、血液和组织等生物检体，以识别、诊断和追踪疾病的进展。市场成长的主要驱动力是全球慢性病（例如糖尿病和心血管疾病）盛行率的不断上升，这些疾病需要频繁且细緻的监测。此外，人口老化加剧也推动了对诊断服务的需求，因为老年人通常需要更密集的医疗管理。这些人口和流行病学因素为检测量的成长奠定了坚实的基础，确保了市场持续成长，且这种成长不依赖任何特定的技术趋势。

然而，市场扩张的一大障碍是合格实验室技术人员的严重短缺，这限制了营运扩充性和检测能力。人才短缺造成了瓶颈，阻碍了检查室高效处理日益增长的检体量。根据美国临床病理学会的数据，到2025年，解剖病理科的空缺率将达到28.5%。这种人员短缺可能导致诊断结果延迟，并限制基本服务的提供，这可能会阻碍全球临床检测市场的整体成长。

市场驱动因素

诊断自动化技术的进步和人工智慧 (AI) 的整合正在提高工作流程效率和诊断准确性。检查室正在加速采用人工智慧来管理复杂的生物数据并实现常规任务的自动化，这是在满足日益增长的检测量的同时减少人为干预的关键一步。这项技术进步也体现在监管领域，美国食品药物管理局(FDA) 报告称，截至 2024 年 8 月，已有 950 种支援人工智慧/机器学习的医疗设备核准。这些创新有助于减轻检查室的…

私营和独立临床实验室网路的扩张正透过策略整合推动进一步成长。大型商业诊断机构正积极开展医院推广计画并收购小规模的区域实验室，旨在集中检测业务并优化供应链成本。这种大规模网路扩张的趋势需要大量的资本投资。例如，Quest Diagnostics在2024年7月的新闻稿中宣布，已达成最终协议，将以约13.5亿加元的价格收购总部位于加拿大的LifeLabs。此类整合确保了在全球市场持续扩充性，并维持了可观的收入规模。罗氏诊断部门2024年上半年的销售额达到72亿瑞士法郎，便印证了这一点。

市场挑战

合格实验室技术人员的严重短缺严重限制了实验室的运作能力，并严重阻碍了全球临床检测市场的发展。慢性病的高发生率推动了诊断检测的需求，但由于缺乏足够的合格人员来检验结果和管理复杂的流程，实验室难以扩展服务。自动化虽然提高了效率，但并不能取代分析前和分析后阶段熟练的监管人员。因此，人才短缺直接导致流程瓶颈和周转时间延长，限制了创收检测的总量，并削弱了市场需求成长带来的潜在收入成长。

劳动力短缺加剧了营运负担，威胁到实验室服务的长期永续性。随着经验丰富的人才离开这个行业，培训新员工和维持服务连续性的能力也随之下降。根据美国临床病理学会 (ASCP) 2025 年的一项调查，17 个实验室部门中有 10 个报告称其人员流动率高于历史平均值。这种人员流动加速而补充人员不足的趋势加剧了人员短缺危机，并确保服务可用性将继续成为市场扩张的关键阻碍因素。

市场趋势

家用自采试剂盒的日益普及正在从根本上改变患者的就医方式，它分散了诊断流程，并赋予消费者管理自身健康的能力。这一趋势使常规体检不再局限于传统的采血中心，患者可以在家中进行非侵入性检体采集，用于检测健康状况指标和慢性病等各种疾病。诊断服务提供者正积极利用这一转变，将市场需求旺盛的检测项目添加到其面向消费者的产品组合中，从而在传统医生转诊之外开闢新的收入来源。例如，Quest Diagnostics公司公布，截至2025年1月的财年，年收入达98.7亿美元，主要得益于其主导消费者的检测平台策略性扩张，目前已涵盖约135项健康和保健检测项目。

同时，个人化医疗和伴随诊断的蓬勃发展正在改变检测服务格局，它将先进的基因组学和分子检测技术整合起来，以指导标靶治疗介入。製药公司和诊断试剂开发商正在协调各自的研发管线，以识别特定的生物标记物，并将患者与肿瘤和免疫治疗方案相匹配。这使得高复杂度检测成为临床诊疗的常规组成部分。治疗研发与诊断准确性之间的这种协同作用，即使在疫情导致检测量下降的情况下，也为主要产业参与者维持了稳定的收入来源。根据罗氏于2025年1月公布的2024财年全年财务业绩，其诊断部门的销售额达到143亿瑞士法郎，核心业务增长8%，这主要得益于市场对用于高级临床决策支持的免疫诊断和分子解决方案的强劲需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球临床检测市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（血液常规检查、血红素/血球容积比测试、基础代谢指标测试、尿素氮/肌酸酐测试、电解质测试、糖化血红蛋白测试、综合代谢指标测试、肝功能测试、血脂测试、肾功能测试、心血管测试）
  • 依最终使用者（中心检查室、基层医疗诊所）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美临床检测市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲临床检测市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区临床检测市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲临床检测市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲临床检测市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球临床检测市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Quest Diagnostics Incorporated
• Abbott Laboratories Inc.
• Cinven Group
• Laboratory Corporation of America Holdings
• Arup Laboratories Inc.
• Opko Health, Inc.
• Unilabs Diagnostics AB
• Clinical Reference Laboratory, Inc.
• Synnovis Group Llp
• Sonic Healthcare Limited

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Clinical Laboratory Tests Market is projected to expand from USD 127.24 Billion in 2025 to USD 214.45 Billion by 2031, registering a CAGR of 9.09%. These specialized medical assessments involve the analysis of biological specimens, such as urine, blood, and tissue, to identify, diagnose, and track disease progression. Market growth is primarily fueled by the increasing global prevalence of chronic disorders, such as diabetes and cardiovascular conditions, which require frequent and precise monitoring. Additionally, the growing geriatric population drives demand for diagnostic services, as older adults typically necessitate more intensive healthcare management. These demographic and epidemiological factors establish a solid foundation for testing volumes, ensuring sustained growth independent of specific technological trends.

However, a significant obstacle to market expansion is the acute shortage of qualified laboratory professionals, which restricts operational scalability and testing capacity. This workforce gap creates bottlenecks that hinder the ability of laboratories to efficiently process rising sample volumes. Data from the American Society for Clinical Pathology indicates that in 2025, the vacancy rate for anatomic pathology departments stood at 28.5 percent. Such staffing deficiencies threaten to delay diagnostic results and impede the broader growth of the global clinical laboratory tests market by limiting the availability of essential services.

Market Driver

Technological progress in diagnostic automation and the integration of artificial intelligence is refining workflow efficiency and diagnostic accuracy. Laboratories are increasingly adopting AI to manage complex biological data and automate routine tasks, a crucial step for handling higher testing volumes with less manual intervention. This technological momentum is reflected in the regulatory landscape; the U.S. Food and Drug Administration reported in August 2024 that 950 AI/ML-enabled medical devices had been authorized. These innovations help alleviate workforce shortages while enabling the deployment of sophisticated diagnostic algorithms, ensuring labs can meet modern throughput demands.

The proliferation of private and independent clinical laboratory networks is further driving growth through strategic consolidation. Major commercial diagnostic entities are acquiring hospital outreach programs and smaller regional labs to centralize testing operations and optimize supply chain costs. This trend toward large-scale network expansion involves significant capital investment; for instance, Quest Diagnostics announced in a July 2024 press release a definitive agreement to acquire the Canadian provider LifeLabs for approximately CAN $1.35 billion. Such consolidation ensures the continued scalability of the global market, sustaining substantial revenue volumes, as evidenced by Roche's Diagnostics Division reporting half-year sales of CHF 7.2 billion in 2024.

Market Challenge

The severe shortage of qualified laboratory professionals places a hard ceiling on operational capacity, significantly hampering the Global Clinical Laboratory Tests Market. While the prevalence of chronic diseases drives up demand for diagnostic testing, laboratories cannot scale their services without sufficient certified personnel to validate results and manage complex workflows. Although automation enhances efficiency, it does not eliminate the need for skilled oversight during pre-analytical and post-analytical phases. Consequently, workforce deficits directly result in processing bottlenecks and extended turnaround times, which restricts the overall volume of monetizable tests and erodes potential revenue gains from rising market demand.

This operational strain is intensified by a shrinking workforce demographic that threatens the long-term sustainability of testing services. As experienced personnel leave the field, the capacity to train new recruits and maintain service continuity diminishes. According to the American Society for Clinical Pathology in 2025, 10 out of 17 laboratory departments reported rising retirement rates compared to previous cycles. This trend of accelerating retirements without adequate replacement deepens the staffing crisis, ensuring that service availability remains a primary constraint on market expansion.

Market Trends

The increasing utilization of at-home self-collection and sampling kits is fundamentally transforming patient access by decentralizing diagnostic workflows and empowering consumers to proactively manage their health. This trend shifts routine screening away from traditional phlebotomy centers, allowing patients to perform non-invasive sample collection for conditions ranging from wellness markers to chronic disease monitoring in private settings. Diagnostic providers are aggressively capitalizing on this shift by expanding their direct-to-consumer portfolios to include high-demand assays, creating new revenue channels that bypass traditional physician referrals. For example, Quest Diagnostics reported full-year revenues of $9.87 billion in its January 2025 financial results, a performance supported by the strategic expansion of its consumer-initiated test platform to include approximately 135 distinct health and wellness tests.

Concurrently, the growth of personalized medicine and companion diagnostics is altering laboratory service menus as providers integrate advanced genomic and molecular testing to guide targeted therapeutic interventions. Pharmaceutical and diagnostic developers are synchronizing their pipelines to ensure specific biomarkers can be identified to match patients with oncology and immunology treatments, thereby making high-complexity assays a standard component of clinical care. This synergy between therapeutic development and diagnostic precision sustains revenue streams for major industry players even as pandemic-related testing volumes decline. As reported in its 2024 full-year results released in January 2025, Roche's Diagnostics Division generated sales of CHF 14.3 billion, with the base business growing 8% largely due to strong demand for immunodiagnostic and molecular solutions supporting advanced clinical decision-making.

Key Market Players

• Quest Diagnostics Incorporated
• Abbott Laboratories Inc.
• Cinven Group
• Laboratory Corporation of America Holdings
• Arup Laboratories Inc.
• Opko Health, Inc.
• Unilabs Diagnostics AB
• Clinical Reference Laboratory, Inc.
• Synnovis Group Llp
• Sonic Healthcare Limited

Report Scope

In this report, the Global Clinical Laboratory Tests Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Laboratory Tests Market, By Type

• Complete Blood Count
• HGB/HCT Testing
• Basic Metabolic Panel Testing
• BUN Creatinine Testing
• Electrolytes Testing
• HbA1c Testing
• Comprehensive Metabolic Panel Testing
• Liver Panel Testing
• Lipid Panel Testing
• Renal Panel Testing
• Cardiovascular Panel Tests

Clinical Laboratory Tests Market, By End User

• Central Laboratories
• Primary Clinics

Clinical Laboratory Tests Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Laboratory Tests Market.

Available Customizations:

Global Clinical Laboratory Tests Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Laboratory Tests Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Complete Blood Count, HGB/HCT Testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Lipid Panel Testing, Renal Panel Testing, Cardiovascular Panel Tests)
  • 5.2.2. By End User (Central Laboratories, Primary Clinics)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Clinical Laboratory Tests Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Clinical Laboratory Tests Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Clinical Laboratory Tests Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Clinical Laboratory Tests Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Clinical Laboratory Tests Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Clinical Laboratory Tests Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. France Clinical Laboratory Tests Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Clinical Laboratory Tests Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Clinical Laboratory Tests Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Clinical Laboratory Tests Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia Pacific Clinical Laboratory Tests Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Clinical Laboratory Tests Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Clinical Laboratory Tests Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Clinical Laboratory Tests Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Clinical Laboratory Tests Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Clinical Laboratory Tests Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. Middle East & Africa Clinical Laboratory Tests Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Clinical Laboratory Tests Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Clinical Laboratory Tests Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Clinical Laboratory Tests Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. South America Clinical Laboratory Tests Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Clinical Laboratory Tests Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Clinical Laboratory Tests Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Clinical Laboratory Tests Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Clinical Laboratory Tests Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Quest Diagnostics Incorporated
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Abbott Laboratories Inc.
• 15.3. Cinven Group
• 15.4. Laboratory Corporation of America Holdings
• 15.5. Arup Laboratories Inc.
• 15.6. Opko Health, Inc.
• 15.7. Unilabs Diagnostics AB
• 15.8. Clinical Reference Laboratory, Inc.
• 15.9. Synnovis Group Llp
• 15.10. Sonic Healthcare Limited

16. Strategic Recommendations

17. About Us & Disclaimer